Antimicrobial Peptides Market

Antimicrobial peptides (AMPs), also called host defense peptides (HDPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
Antimicrobial Peptides Market aims to provide a comprehensive presentation of the global market for Antimicrobial Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antimicrobial Peptides. Antimicrobial Peptides Market contains market size and forecasts of Antimicrobial Peptides in global, including the following market information:
Global Antimicrobial Peptides Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Antimicrobial Peptides Market Sales, 2018-2023, 2024-2029, (Mg)
Global top five Antimicrobial Peptides companies in 2022 (%)
The global Antimicrobial Peptides market was valued at US$ 5 million in 2022 and is projected to reach US$ 7 million by 2029, at a CAGR of 5.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in the industry are AnaSpec, AMP Biotech, Phoenix Biotech and Novabiotics, with revenues of about 7%, 9%, 3% and about 26% respectively in 2019.
By region, North America had the highest share of sales, at about 35%.
We surveyed the Antimicrobial Peptides manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Plant Antimicrobial Peptides
• Microbial Antimicrobial Peptides
• Animal Antimicrobial Peptides

• Pharmaceuticals
• Feed Additives
• Others

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Antimicrobial Peptides revenues in global market, 2018-2023 (Estimated), ($ millions)
• Key companies Antimicrobial Peptides revenues share in global market, 2022 (%)
• Key companies Antimicrobial Peptides sales in global market, 2018-2023 (Estimated), (Mg)
• Key companies Antimicrobial Peptides sales share in global market, 2022 (%)

• AnaSpec
• AMP Biotech
• Phoenix Biotech
• Novabiotics
• Chinese Peptide
• Ontores
• GenScript
• Hycult Biotech
• Sunsmile
• Ruixing Biotechnology
• Zhongnong Yingtai Biotechnology
• Glam Technology
• ProteLight Pharmaceutical & Biotechnology

• Chapter 1: Introduces the definition of Antimicrobial Peptides, market overview.
• Chapter 2: Global Antimicrobial Peptides market size in revenue and volume.
• Chapter 3: Detailed analysis of Antimicrobial Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Antimicrobial Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Antimicrobial Peptides capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.